comparemela.com

Page 14 - Josh Nathan Kazis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pfizer s Earnings Are Tuesday Here s What to Expect

The drug maker Pfizer is set to disclose its results. Investors are focused on Covid-19 drugs despite a recent flurry of product launches.

Josh nathan kazisGetty imagesEli lillyNovo nordiskArticle normalAgricultural machineryHealthcare life sciencesIndustrial goodsFinancial performanceSales figuresCorporate industrial newsPolitical general newsRespiratory tract diseasesMedical conditionsNovel coronavirusesInfectious diseases

Sanofi Will Carve Out Consumer Health Division in Bid to Invest More in Science

The stand-alone division will be the latest addition to a growing list of such public companies recently spun out of larger drugmakers.

France generalUnited statesJosh nathan kazisPaul hudsonThomas samsonBoehringer ingelheimCenters for diseaseGetty imagesDisease controlArticle normalCosmetics toiletriesHealthcare life sciencesConsumer goodsPersonal care products appliancesCorporate industrial newsBiotech and pharma

Biogen and Eisai s Injected Alzheimer s Drug Works, but Safety Questions Linger

Wall Street analysts say Biogen and Eisai could secure Food and Drug Administration approval for their injected Alzheimer’s drug.

Mark goodmanJosh nathan kazisWilliam blairMyles minterPhil nadeauDrug administrationWall streetEli lillyLeerink partnersArticle normalBiotechnology servicesAgricultural machineryCommercial bankingHealthcare life sciencesBanking creditSpecialized drugs medications

GSK and Other Companies Push Forward With RSV Vaccine Amid Shortages

The U.K. drugmaker GSK is seeking to expand regulatory approval for its new respiratory syncytial virus vaccine to include younger adults.

United statesTony woodJosh nathan kazisKsenia kuleshova bloombergAkash tewariCenters for diseaseDisease controlArticle normalRetail wholesaleHealthcare life sciencesSpecialized drugs medicationsRegulation government policyNew products servicesProduct service approvalsCorporate industrial newsProducts services

Merck s Earnings Are Thursday Here s What to Expect

Pharmaceutical stocks have generally fallen, partly because of regulatory concerns, but also because high interest rates have made the companies dividends.

Chris shibutaniAcceleron pharmaDaiichi sankyoAstellas pharmaJosh nathan kazisGoldman sachsArticle normalBiotechnology servicesCancer drugsHealthcare life sciencesSpecialized drugs medicationsRegulation government policyFinancial performanceCorporate industrial newsPolitical general newsMedical conditions

vimarsana © 2020. All Rights Reserved.